PitchSend

Investor Presentaiton

2Q15 Business Segment Highlights 17 USD (in millions) 2Q15 2Q14 YoY% Others 10% Patient Monitor and Life Support 109.7 119.3 -8.1% MIS 26% US$ 337mm In-Vitro Diagnostics 104.5 98.3 6.3% Medical Imaging Systems 88.3 84.6 4.4% Others 34.3 32.2 6.4% IVD/ 31% PMLS 33% ■PMLS: Most lines were impacted by the slow demand in our major markets. IVD: Reagent sales led the overall IVD sales growth and contributed 48.8% to total segment sales. ■MIS: Our radiology products were the major growth driver. The newly introduced high-end portable ultrasound, the M9, also performed well, particularly in developed markets. Others: Increasing after-sales services was the key growth driver. mindray

View entire presentation